USE OF BI-RADS TO INTERPRET MAGNETIC RESONANCE MAMMOGRAPHY FOR BREAST CANCER
https://doi.org/10.20862/0042-4676-2014-0-4-46-59
Abstract
The Breast Imaging Reporting and Data System (BI-RADS) is a practical tool developed by the American College of Radiology to standardize the description of mammography, ultrasound study, and magnetic resonance mammography. BI-RADS includes recommendations for the structure of a protocol to describe radiologic studies; terminology to characterize three major types of lesions (focus, mass, contrasting area); as well as assessment categories and their corresponding recommendations for further patient management. The publication gives general information on the new edition of BI-RADS (2013) and illustrates its use to interpret magnetic resonance mammograms in breast cancer. The wider introduction of BI-RADS at all stages from screening to diagnostic verification will improve the quality of diagnosis and prognosis in breast tumor diseases.
About the Authors
S. A. Kharuzhyk
N.N. Alexandrov Republican Scientific-and-Practical Center of Oncology and Medical Radiology
Belarus
Belarus
MD, PhD, Associate Professor, Radiologist
poselok Lesnoy, 2, Minskiy rayon, 223040
S. V. Shymanets
N.N. Alexandrov Republican Scientific-and-Practical Center of Oncology and Medical Radiology
Belarus
Belarus
Junior Research Associate of Diagnostic Department with a Group of Beam Diagnostics
poselok Lesnoy, 2, Minskiy rayon, 223040
A. V. Karman
N.N. Alexandrov Republican Scientific-and-Practical Center of Oncology and Medical Radiology
Belarus
Belarus
MD, PhD, Leading Research Associate, Head of Group of Beam Diagnostics
poselok Lesnoy, 2, Minskiy rayon, 223040
E. V. Shapoval
N.N. Alexandrov Republican Scientific-and-Practical Center of Oncology and Medical Radiology
Belarus
Belarus
MD, PhD, DSc, Head of Department of Mammologic Oncology with Gynecologic Oncology Group
poselok Lesnoy, 2, Minskiy rayon, 223040
References
1. Статистика онкологических заболеваний в Республике Беларусь (2003–2012). Под ред. О.Г. Суконко. Минск: РНПЦ ОМР им. Н.Н. Александрова; 2013. Cancer statistics in the Republic of Belarus (2003–2012). Ed. O.G. Sukonko. Minsk; 2013 (in Russian).
2. Rausch D.R., Hendrick R.E. How to optimize clinical breast MR imaging practices and techniques on your 1.5-T system. Radiographics. 2006; 26 (5): 1469–84.
3. Peters N.H., Borel Rinkes I.H., Zuithoff N.P. et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008; 246: 116–24.
4. Tsushima Y., Takahashi-Taketomi A., Endo K. Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J. Magn. Reson. Imaging. 2009; 30: 249–55.
5. Yabuuchi H., Matsuo Y., Okafuji T. et al. Enhanced mass on contrastenhanced breast MR imaging: lesion characterization using combination of dynamic contrastenhanced and diffusion-weighted MR images. J. Magn. Reson. Imaging. 2008; 28: 1157–65.
6. Breast Imaging Reporting and Data System (BI-RADS). 4th Ed. Reston: American College of Radiology; 2003.
7. ACR BI-RADS. Система описания и обработки данных исследования молочной железы. Маммологический атлас. Под ред. В.Е. Синицына. М.: Медпрактика-М; 2010.
8. Morris E.A., Comstock C.E., Lee C.H. et al. ACR BI-RADS Magnetic Resonance Imaging. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology; 2013.
9. Timmers J.M., van Doorne-Nagtegaal H.J., Zonderland H.M. et al. The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool. Eur. Radiol. 2012; 22 (8): 1717–23.
10. Захарова Н.А., Даффи С.В., Котляров Е.В. и др. Итоги реализации маммографического скрининга в Окружной клинической больнице Ханты-Мансийска. Опухоли женской репродуктивной системы. 2011; 3: 6–8. Zakharova N.A., Duffi S.V., Kotlyarov E.V. et al. The results of the implementation of mammography screening in the District Hospital of Khanty-Mansiysk. Opukholi zhenskoy reproduktivnoy sistemy. 2011; 3: 6–8 (in Russian).
11. National Comprehensive Cancer Network (NCCN). Breast Cancer Screening and Diagnosis (Version 2.2013). Available at: http:// www.nccn.org/professionals/physi cian_gls/pdf/breast-screening.pdf (accessed 24 February 2014).
12. Hamy A.S., Giacchetti S., Albiter M. et al. BI-RADS categorisation of 2,708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit. Eur. Radiol. 2012; 22 (1): 9–17.
13. Mann R.M., Kuhl C.K., Kinkel K., Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur. Radiol. 2008; 18: 1307–18.
14. Хоружик С.А., Козловская Н.А. Организация и первый опыт клинического использования магнитно-резонансной маммографии. Новейшие технологии лучевой визуализации заболеваний скелета и внутренних органов: Материалы научно-практической конференции. Минск; 2013: 132–5. Kharuzhyk S.A., Kozlovskaja N.A. Organization and the first clinical experience with the use of magnetic resonance mammography. In: The latest technologies of diagnostic imaging in diseases of the skeleton and internal organs: Proc. scientific-practical conf. Minsk; 2013: 132–5 (in Russian).
15. МРТ молочных желез и BIRADS (2013). Available at: http:// nld.by/omr/breast (accessed 24 February 2014). MRI of breast and BI-RADS (2013). Available at: http://nld.by/ omr/breast (accessed 24 February 2014).
16. Хоружик С.А., Шиманец С.В., Карман А.В. МРТ-характеристика рака молочной железы при одиночном поражении. Онкологический журнал. 2013; 7 (4): 57. Kharuzhyk S.A., Shymanets S.V., Carman A.V. MRI characteristics of breast cancer in a single lesion. J. Oncol. 2013; 7 (4): 57 (in Russian).
17. Erguvan-Dogan B., Whitman G.J., Kushwaha A.C. et al. BI-RADSMRI: a primer. Am. J. Roentgenol. 2006; 187 (2): W152–60.
18. Cheng L., Li X. Breast magnetic resonance imaging: non-mass-like enhancement. Gland. Surgery. 2012; 1 (3): 176–88.
19. Rosen E.L., Smith-Foley S.A., DeMartini W.B. et al. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J. 2007; 13 (6): 545–50.
20. Liberman L., Morris E.A., Dershaw D.D. et al. Ductal enhancement on MR Imaging of the breast. Am. J. Roentgenol. 2003; 181: 519–25.
21. Kaiser W.A. Signs in MR-Mammography. Berlin, Heidelberg, New York: Springer; 2008.
22. Baum F., Fischer U., Vosshenrich R., Grabbe E. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur. Radiol. 2002; 12: 1087–92.
23. Fischer U., Kopka L., Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999; 213 (3): 881–8.
24. Barentsz J.O., Richenberg J., Clements R. et al. ESUR prostate MR guidelines 2012. Eur. Radiol. 2012; 22: 746–57.
25. Dromain C., Boyer B., Ferre R. et al. Computed-aided diagnosis (CAD) in the detection of breast cancer. Eur. J. Radiol. 2013; 82: 417–23.
26. Park M.J., Cha E.S., Kang B.J. et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J. Radiol. 2007; 8: 390–96.
27. Thomassin-Naggaraa I., De Bazelaireb C., Chopier J. et al. Diffusion-weighted MR imaging of the breast: Advantages and pitfalls. Eur. J. Radiol. 2013; 82: 435–43.
Review
For citations:
Kharuzhyk S.A., Shymanets S.V., Karman A.V., Shapoval E.V. USE OF BI-RADS TO INTERPRET MAGNETIC RESONANCE MAMMOGRAPHY FOR BREAST CANCER. Journal of radiology and nuclear medicine. 2014;(4):46-59. (In Russ.) https://doi.org/10.20862/0042-4676-2014-0-4-46-59
Views:
4822
Email this article 